First interim analysis of the German prospective, non-interventional study PaVe: first results on the clinical routine of ruxolitinib in polycythemia vera

被引：0
|
作者：
Griesshammer, M. [1 ]
von der Heyde, E. [2 ]
Weide, R. [3 ]
Reichert, D. [4 ]
Weniger, J. [5 ]
Schlag, R.
Hutzschenreuter, U. [6 ]
Becker, M. [7 ]
Just, M.
Hacker, E. [8 ]
Cavanna, D. [8 ]
Lengfelder, E. [9 ]
机构：
[1] Johannes Wesling Klinikum, Minden, Germany
[2] Gemeinschaftspraxis Dres Zander von der Heyde, Hannover, Germany
[3] Praxisklin Hamatol & Onkol, Koblenz, Germany
[4] Onkol Gemeinschaftspraxis Dres Reichert Janssen, Westerstede, Germany
[5] Gemeinschaftspraxis Hamatol & Onkol Dres Weniger, Erfurt, Germany
[6] Hamatol Onkol Gemeinschaftspraxis Dres Hutzschenr, Nordhorn, Germany
[7] Zentrum Hamatol & Onkol MVZ GmbH, Porta Westfalica, Germany
[8] Novartis Pharma GmbH, Nurnberg, Germany
[9] Univ Med Mannheim, Med Klin 3, Mannheim, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2017年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P544
引用
收藏
页码：148 / +
页数：2
相关论文
共 50 条
  • [31] Olaparib routine clinical practice in Germany - Interim results of the non-interventional C-PATROL study reflecting routine BRCA mutational testing
    Sehouli, J.
    Hilpert, F.
    Welslau, M.
    Schinkoethe, T.
    El-Balat, A.
    Grischke, E. M.
    Glowik, R.
    Marme, F.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 87 - 87
  • [32] TOCILIZUMAB IN RHEUMATOID ARTHRITIS - ANNUAL INTERIM ANALYSIS OF THE GERMAN NON-INTERVENTIONAL STUDY ICHIBAN
    Specker, C.
    Kaufmann, J.
    Kellner, H.
    Bohl-Buehler, M.
    Schwenke, H.
    Vollmer, M. A.
    Kapelle, A.
    Zinke, S.
    Hofmann, M. W.
    Hellmann, P.
    Fliedner, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 879 - 879
  • [33] First line therapy with Bendamustine in advanced indolent Non-Hodgkin Lymphoma in treatment routine - interim analysis of the non-interventional study Be-1st
    Becker, M.
    Tschechne, B.
    Reeb, M.
    Schwinger, U.
    Grass, J.
    Strassl, L.
    ONKOLOGIE, 2011, 34 : 268 - 268
  • [34] NADIR: A Non-Interventional Study on the Prophylaxis of Chemotherapy-Induced Neutropenia Using Lipegfilgrastim - First Interim Analysis
    Kurbacher, Christian M.
    Fietz, Thomas
    Diel, Ingo J.
    Egert, Matthias
    Hurtz, Hans-Juergen
    Lueck, Andreas
    Weide, Rudolf
    Salat, Christoph
    Wolff, Thomas
    Zaiss, Matthias
    Klare, Peter
    Losem, Christoph
    Illmer, Thomas
    Weissenborn, Georg
    Steffens, Claus-Christoph
    Schulze, Matthias
    Tesch, Hans
    Oskay-Oezcelik, Guelten
    Teichmann, Beate
    Harde, Johanna
    Scheuerlein, Robert Willy
    ONCOLOGY RESEARCH AND TREATMENT, 2015, 38 (05) : 221 - 229
  • [35] Trifluridine/tipiracil in patients with refractory metastatic colorectal cancer in clinical routine in Germany: Interim results of the non-interventional study TACTIC
    Schwaner, I
    Goehler, T.
    Decker, T.
    Grundeis, M.
    Sauer, A.
    Fichter, C.
    Moorahrend, E.
    Kroening, H.
    Lipke, J.
    Kojouharoff, G.
    Frank, M.
    Hogrefe, C.
    Marschner, N.
    Potthoff, K.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 130 - 131
  • [36] Patients switching to fingolimod in daily clinical routine: 2 year interim results from the non-interventional study PANGAEA 2.0
    Schulze-Topphoff, U.
    Ettle, B.
    Cornelissen, C.
    Ziemssen, T.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 932 - 932
  • [37] IRON CHELATION THERAPY IN MYELODYSPLASTIC SYNDROME (MDS) IN ROUTINE CLINICAL SETTING: AN INTERIM ANALYSIS OF THE NON-INTERVENTIONAL STUDY EXSEPT
    Nolte, F.
    Rubanov, O.
    Kuehn, R. -B.
    Schumann, C.
    Kreil, S.
    Metzgeroth, G.
    Johr, C.
    Albrecht, S.
    Hofmann, W. -K.
    HAEMATOLOGICA, 2015, 100 : 490 - 490
  • [38] Deferasirox in the routine-treatment of MDS patients with chronic iron overload: interim results from the non-interventional, prospective study EXSEPT
    Nolte, F.
    Schumann, C.
    Bueckner, U.
    Schmidt, B.
    Hebart, H.
    Rubanov, O.
    Kuehn, R-B
    Kreil, S.
    Metzgeroth, G.
    Johrs, C.
    Albrecht, S.
    Bach, T.
    Hofmann, W-K
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 60 - 60
  • [39] FIRST INTERIM ANALYSIS OF PATIENT-REPORTED OUTCOMES IN VIEW STUDY: A MULTICENTER, SINGLEARM, PROSPECTIVE, NON-INTERVENTIONAL STUDY OF VONOPRAZAN IN REAL-WORLD CLINICAL PRACTICE IN CHINA
    Xiao, Y.
    Wang, Q.
    Li, G.
    Nail, A.
    Song, Q.
    Xie, L.
    Chen, M.
    VALUE IN HEALTH, 2023, 26 (12) : S448 - S449
  • [40] Efficacy of Afatinib in the clinical practice - first results of the GIDEON trial: a prospective non-interventional study (NIS) in EGFR mutated NSCLC in Germany
    Rawluk, J.
    Reck, M.
    Laack, E.
    Griesinger, F.
    Schaefer, H.
    Kortsik, C.
    Gaska, T.
    Krueger, S.
    Kokowski, K.
    Budweiser, S.
    Schueler, A.
    Hoffmann, C.
    Brueckl, W.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 210 - 211
12345